Understanding variation in quality of antibiotic use for community-acquired pneumonia: Effect of patient, professional and hospital factors

Journal of Antimicrobial Chemotherapy

Volumn 56, Issue 3, 2005, Pages 575-582

  Schouten, Jeroen A ^a   Hulscher, Marlies E ^a   Kullberg, Bart Jan ^a   Cox, Anton ^a   Gyssens, Inge C ^b   van der Meer, Jos W ^a   Grol, Richard P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Antibiotic therapy; CAP; Determinants; Multilevel analysis; Quality of care

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG UTILIZATION; FEMALE; HEALTH CARE QUALITY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; OXYGEN SATURATION; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRESCRIPTION; PROSPECTIVE STUDY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

AGED; ANTI-BACTERIAL AGENTS; BLOOD; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; GUIDELINE ADHERENCE; HOSPITALS; HUMANS; KIDNEY DISEASES; LEGIONELLA; MALE; MIDDLE AGED; NETHERLANDS; PHYSICIAN'S PRACTICE PATTERNS; PNEUMONIA, BACTERIAL; PRESCRIPTIONS, DRUG; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; REGRESSION ANALYSIS; SPUTUM; URINE;

EID: 24644484244     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dki275     Document Type: Article

References (43)

1. Fine MJ, Smith MA, Carson CA et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 1996; 275: 134-41.
2. Fine MJ, Stone RA, Singer DE et al. Processes and outcomes of care for patients with community-acquired pneumonia: Results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study. Arch Intern Med 1999; 159: 970-80.
3. Lawrence M, Olesen F. Indicators of quality in health care. Eur J Gen Pract 1997; 3: 103-8.
4. Barlow GD, Lamping DL, Davey PG et al. Evaluation of outcomes in community-acquired pneumonia: A guide for patients, physicians, and policy-makers. Lancet Infect Dis 2003; 3: 476-88.
5. Nathwani D, Williams F, Winter J et al. Use of indicators to evaluate the quality of community-acquired pneumonia management. Clin Infect Dis 2002; 34: 318-23.
6. Rhew DC, Goetz MB, Shekelle PG. Evaluating quality indicators for patients with community-acquired pneumonia. Jt Comm J Qual Improv 2001; 27: 575-90.
7. Meehan TP, Fine MJ, Krumholz HM et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 1997; 278 2080-4.
8. Battleman DS, Callahan M, Thaler HT. Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: Link between quality of care and resource utilization. Arch Intern Med 2002; 162: 682-8.
9. Menendez R, Ferrando D, Valles JM et al. Influence of deviation from guidelines on the outcome of community-acquired pneumonia. Chest 2002; 122: 612-7.
10. Gleason PP, Meehan TP, Fine JM et al. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med 1999; 159: 2562-72.
11. Martinez JA, Horcajada JP, Almela M et al. Addition of a macrolide to a β-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2003; 36: 389-95.
12. Stahl JE, Barza M, DesJardin J et al. Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia. Arch Intern Med 1999; 159 2576-80.
13. Waterer GW, Somes GW, Wunderink RG. Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch Intern Med 2001; 161: 1837-42.
14. Atlas SJ, Benzer TI, Borowsky LH et al. Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: An interventional trial. Arch Intern Med 1998; 158 1350-6.
15. Ramirez JA, Vargas S, Ritter GW et al. Early switch from intravenous to oral antibiotics and early hospital discharge: A prospective observational study of 200 consecutive patients with community-acquired pneumonia. Arch Intern Med 1999; 159: 2449-54.
16. Rhew DC, Tu GS, Ofman J et al. Early switch and early discharge strategies in patients with community-acquired pneumonia: A meta-analysis. Arch Intern Med 2001; 161: 722-7.
17. Sanyal S, Smith PR, Saha AC et al. Initial microbiologic studies did not affect outcome in adults hospitalized with community-acquired pneumonia. Am J Respir Crit Care Med 1999; 160: 346-8.
18. Byl B, Clevenbergh P, Jacobs F et al. Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis 1999; 29 60-6.
19. Dedier J, Singer DE, Chang Y et al. Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals. Arch Intern Med 2001; 161: 2099-104.
20. Fine JM, Fine MJ, Galusha D et al. Patient and hospital characteristics associated with recommended processes of care for elderly patients hospitalized with pneumonia: Results from the medicare quality indicator system pneumonia module. Arch Intern Med 2002; 162: 827-33.
21. Halm EA, Atlas SJ, Borowsky LH et al. Understanding physician adherence with a pneumonia practice guideline: Effects of patient, system, and physician factors. Arch Intern Med 2000; 160: 98-104.
22. Schouten JA, Hulscher ME, Wollersheim H et al. Quality of antibiotic use for lower respiratory tract infections at hospitals: (how) can we measure it? Clin Infect Dis 2005; 41: 450-60.
23. van Kasteren ME, Wijnands WJ, Stobberingh EE et al. Optimization of the antibiotics policy in the Netherlands. II. SWAB guidelines for the antimicrobial therapy of pneumonia in patients at home. The Netherlands Antibiotic Policy Foundation. Ned Tijdschr Geneeskd 1998; 142: 952-6.
24. NVALT (National Society for Respiratory Physicians). Guideline for Diagnosis and Treatment of Community-acquired Pneumonia (CAP). Alphen aan den Rijn: Van Zuiden Communications, 2003.
25. ERS Task Force Report. Guidelines for management of adult community-acquired lower respiratory tract infections. European Respiratory Society. Eur Respir J 1998; 11: 986-91.
26. British Thoracic Society Standards of Care Committee. BTS Guidelines for the Management of Community Acquired Pneumonia in Adults. Thorax 2001; 56 Suppl 4: Iv1-64.
27. Bartlett JG, Dowell SF, Mandell LA et al. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 2000; 31: 347-82.
28. Niederman MS, Mandell LA, Anzueto A et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163: 1730-54.
29. Quality of care improvements for patients with pneumonia. Florida Medical Quality Assurance, Inc. Eval Health Prof 1998; 21: 514-24.
30. Bratzler DW, Murray CK, Bumpus LJ et al. Community-acquired pneumonia in Oklahoma: Characteristics and management of hospitalized Medicare beneficiaries. J Okla State Med Assoc 1996; 89: 87-92.
31. Chu LA, Bratzler DW, Lewis RJ et al. Improving the quality of care for patients with pneumonia in very small hospitals. Arch Intern Med 2003; 163: 326-32.
32. Fortune G, Elder S, Jaco D et al. Opportunities for improving the care of patients with community-acquired pneumonia. Clin Perform Qual Health Care 1996; 4: 41-3.
33. Jencks SF, Cuerdon T, Burwen DR et al. Quality of medical care delivered to Medicare beneficiaries: A profile at state and national levels. JAMA 2000; 284: 1670-6.
34. Metersky ML, Galusha DH, Meehan TP. Improving the care of patients with community-acquired pneumonia: A multihospital collaborative QI project. Jt Comm J Qual Improv 1999; 25: 182-90.
35. Rhew DC. Quality indicators for the management of pneumonia in vulnerable elders. Ann Intern Med 2001; 135: 736-43.
36. Schade CP, Cochran BF, Stephens MK. Using statewide audit and feedback to improve hospital care in West Virginia. Jt Comm J Qual Saf 2004; 30: 143-51.
37. Fine MJ, Auble TE, Yealy DM et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-50.
38. Schouten JA, Hulscher ME, Natsch S et al. Antibiotic control measures in Dutch secondary care hospitals. Neth J Med 2005; 63 24-30.
39. Snijders TE, Bosker RJ. An introduction to basic and advanced multilevel modeling. London: Sage Publications Ltd, 1999.
40. Benenson R, Magalski A, Cavanaugh S et al. Effects of a pneumonia clinical pathway on time to antibiotic treatment, length of stay, and mortality. Acad Emerg Med 1999; 6: 1243-8.
41. Lawrence SJ, Shadel BN, Leet TL et al. An intervention to improve antibiotic delivery and sputum procurement in patients hospitalized with community-acquired pneumonia. Chest 2002; 122: 913-9.
42. Waterer GW. Combination antibiotic therapy with macrolides in community-acquired pneumonia: More smoke but is there any fire? Chest 2003; 123: 1328-9.
43. Kuyvenhoven MM, van Balen FA, Verheij TJ. Outpatient antibiotic prescriptions from 1992 to 2001 in The Netherlands. J Antimicrob Chemother 2003; 52: 675-8.